project id: TCGA-SARC; case submitter id: TCGA-DX-A6BG; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 2.0; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.45; rna integrity number: 8.8; age at index: 51; days to birth: -18682; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1961; age at diagnosis: 18682; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1121.0; icd 10 code: C48.0; last known disease status: not reported; morphology: 8858/3; primary diagnosis: Dedifferentiated liposarcoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Retroperitoneum; synchronous malignancy: No; tissue or organ of origin: Retroperitoneum; tumor grade: Not Reported; year of diagnosis: 2012; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 170; days to sample procurement: 0; initial weight: 670.0; portion submitter id: TCGA-DX-A6BG-01A-11; percent lymphocyte infiltration: 1.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 75.0;